Cargando…
Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease
BACKGROUND: One-third of patients with non-alcoholic fatty liver disease (NAFLD) develop dysmetabolic iron overload syndrome (DIOS), the pathogenesis of which is unknown. Altered production of the iron-regulatory peptide hepcidin has been reported in NAFLD, but it is unclear if this is related to ir...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989417/ https://www.ncbi.nlm.nih.gov/pubmed/29871592 http://dx.doi.org/10.1186/s12876-018-0804-0 |
_version_ | 1783329458548113408 |
---|---|
author | Marmur, Joel Beshara, Soheir Eggertsen, Gösta Onelöv, Liselotte Albiin, Nils Danielsson, Olof Hultcrantz, Rolf Stål, Per |
author_facet | Marmur, Joel Beshara, Soheir Eggertsen, Gösta Onelöv, Liselotte Albiin, Nils Danielsson, Olof Hultcrantz, Rolf Stål, Per |
author_sort | Marmur, Joel |
collection | PubMed |
description | BACKGROUND: One-third of patients with non-alcoholic fatty liver disease (NAFLD) develop dysmetabolic iron overload syndrome (DIOS), the pathogenesis of which is unknown. Altered production of the iron-regulatory peptide hepcidin has been reported in NAFLD, but it is unclear if this is related to iron accumulation, lipid status or steatohepatitis. METHODS: Eighty-four patients with liver disease, 54 of which had iron overload, underwent liver biopsy (n = 66) and/or magnetic resonance imaging (n = 35) for liver iron content determination. Thirty-eight of the patients had NAFLD, 29 had chronic liver disease other than NAFLD, and 17 had untreated genetic hemochromatosis. Serum hepcidin was measured with ELISA in all patients and in 34 controls. Hepcidin antimicrobial peptide (HAMP) mRNA in liver tissue was determined with real-time-quantitative PCR in 36 patients. RESULTS: Serum hepcidin was increased similarly in NAFLD with DIOS as in the other chronic liver diseases with iron overload, except for genetic hemochromatosis. HAMP mRNA in liver tissue, and serum hepcidin, both correlated to liver iron content in NAFLD patients (r(2) = 0.45, p < 0.05 and r(2) = 0.27, p < 0.05 respectively) but not to body mass index, NAFLD activity score or serum lipids. There was a good correlation between HAMP mRNA in liver tissue and serum hepcidin (r(2) = 0.39, p < 0.01). CONCLUSIONS: In NAFLD with or without dysmetabolic iron overload, serum hepcidin and HAMP mRNA in liver correlate to body iron content but not to the degree of steatohepatitis or lipid status. Thus, the dysmetabolic iron overload syndrome seen in NAFLD is not caused by an altered hepcidin synthesis. |
format | Online Article Text |
id | pubmed-5989417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59894172018-06-20 Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease Marmur, Joel Beshara, Soheir Eggertsen, Gösta Onelöv, Liselotte Albiin, Nils Danielsson, Olof Hultcrantz, Rolf Stål, Per BMC Gastroenterol Research Article BACKGROUND: One-third of patients with non-alcoholic fatty liver disease (NAFLD) develop dysmetabolic iron overload syndrome (DIOS), the pathogenesis of which is unknown. Altered production of the iron-regulatory peptide hepcidin has been reported in NAFLD, but it is unclear if this is related to iron accumulation, lipid status or steatohepatitis. METHODS: Eighty-four patients with liver disease, 54 of which had iron overload, underwent liver biopsy (n = 66) and/or magnetic resonance imaging (n = 35) for liver iron content determination. Thirty-eight of the patients had NAFLD, 29 had chronic liver disease other than NAFLD, and 17 had untreated genetic hemochromatosis. Serum hepcidin was measured with ELISA in all patients and in 34 controls. Hepcidin antimicrobial peptide (HAMP) mRNA in liver tissue was determined with real-time-quantitative PCR in 36 patients. RESULTS: Serum hepcidin was increased similarly in NAFLD with DIOS as in the other chronic liver diseases with iron overload, except for genetic hemochromatosis. HAMP mRNA in liver tissue, and serum hepcidin, both correlated to liver iron content in NAFLD patients (r(2) = 0.45, p < 0.05 and r(2) = 0.27, p < 0.05 respectively) but not to body mass index, NAFLD activity score or serum lipids. There was a good correlation between HAMP mRNA in liver tissue and serum hepcidin (r(2) = 0.39, p < 0.01). CONCLUSIONS: In NAFLD with or without dysmetabolic iron overload, serum hepcidin and HAMP mRNA in liver correlate to body iron content but not to the degree of steatohepatitis or lipid status. Thus, the dysmetabolic iron overload syndrome seen in NAFLD is not caused by an altered hepcidin synthesis. BioMed Central 2018-06-05 /pmc/articles/PMC5989417/ /pubmed/29871592 http://dx.doi.org/10.1186/s12876-018-0804-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Marmur, Joel Beshara, Soheir Eggertsen, Gösta Onelöv, Liselotte Albiin, Nils Danielsson, Olof Hultcrantz, Rolf Stål, Per Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease |
title | Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease |
title_full | Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease |
title_fullStr | Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease |
title_full_unstemmed | Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease |
title_short | Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease |
title_sort | hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989417/ https://www.ncbi.nlm.nih.gov/pubmed/29871592 http://dx.doi.org/10.1186/s12876-018-0804-0 |
work_keys_str_mv | AT marmurjoel hepcidinlevelscorrelatetoliverironcontentbutnotsteatohepatitisinnonalcoholicfattyliverdisease AT besharasoheir hepcidinlevelscorrelatetoliverironcontentbutnotsteatohepatitisinnonalcoholicfattyliverdisease AT eggertsengosta hepcidinlevelscorrelatetoliverironcontentbutnotsteatohepatitisinnonalcoholicfattyliverdisease AT onelovliselotte hepcidinlevelscorrelatetoliverironcontentbutnotsteatohepatitisinnonalcoholicfattyliverdisease AT albiinnils hepcidinlevelscorrelatetoliverironcontentbutnotsteatohepatitisinnonalcoholicfattyliverdisease AT danielssonolof hepcidinlevelscorrelatetoliverironcontentbutnotsteatohepatitisinnonalcoholicfattyliverdisease AT hultcrantzrolf hepcidinlevelscorrelatetoliverironcontentbutnotsteatohepatitisinnonalcoholicfattyliverdisease AT stalper hepcidinlevelscorrelatetoliverironcontentbutnotsteatohepatitisinnonalcoholicfattyliverdisease |